3Indexed trials
drug · Product Intelligence
Capecitabine
Pipeline Intelligence
Capecitabine: 3 indexed trials, 1 sponsors; 0 linked Orange Book patents and 11 FDA-linked events where matched.
1Sponsors
0Orange Book patent links
11FDA-linked events
Development evidence
NCT03221426Merck Sharp & Dohme LLC · parkinsonsPHASE3
NCT03615326Merck Sharp & Dohme LLC · parkinsonsPHASE3
NCT06966700Merck Sharp & Dohme LLC · parkinsonsPHASE3
FDA / patent evidence
Orange Book match found; no listed patent relation was retained for this product match.
Regulatory context
FDA_APPROVALCAPECITABINE · 2024-03-05
FDA_APPROVALCAPECITABINE · 2023-10-23
FDA_APPROVALCAPECITABINE · 2020-12-04
FDA_APPROVALCAPECITABINE · 2018-07-02
FDA_APPROVALCAPECITABINE · 2018-04-17
FDA_APPROVALCAPECITABINE · 2017-11-24
FDA_APPROVALCAPECITABINE · 2016-12-12
FDA_APPROVALCAPECITABINE · 2016-07-14
FDA_APPROVALCAPECITABINE · 2015-04-23
FDA_APPROVALCAPECITABINE · 2013-09-16
FDA_APPROVALXELODA · 1998-04-30
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.